Kinetics of Tc-99m Sestamibi and Tc-99m Tetrofosmin in a Case of Parathyroid Adenoma
- 1 September 1996
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 21 (9) , 700-703
- https://doi.org/10.1097/00003072-199609000-00006
Abstract
The uptake of Tc-99m tetrofosmin (TF) is reported in a case of parathyroid adenoma. A 65-year-old woman was studied on different days with TF, Tc-99m sestamibi (MIBI) and Tl-201 chloride (Tl). TF and MIBI injections were preceded by oral administration of potassium perchlorate. Clear identification of the adenoma was observed in all scans. No further information was obtained using a subtraction technique with Tc-99m pertechnetate. Regarding the thyroid/parathyroid ratio, different kinetics between TF and MIBI appear to be demonstrated. In particular, thyroid washout was observed with MIBI but not with TF.Keywords
This publication has 6 references indexed in Scilit:
- Technetium-99m-tetrofosmin uptake in malignant lung tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Thyroid and parathyroid imagingSeminars in Nuclear Medicine, 1994
- Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Thallium-Technetium Subtraction Scintigraphy of Enlarged Parathyroid Glands after Calcitonin Stimulation of Parathyroid Hormone SecretionActa Radiologica, 1992
- Parathyroid Imaging Use of Dual Isotope Scintigraphy for the Localization of Adenomas before SurgeryClinical Nuclear Medicine, 1992
- Image Normalization and Background Subtraction in TI-201 /Tc-99m Parathyroid Subtraction Scintigraphy Effect on Lesion DetectionClinical Nuclear Medicine, 1992